Salesforce’s Agentforce Life Sciences Selected by AstraZeneca as Its Unified Global Platform to Help Transform Customer Engagement
Salesforce.com Inc (CRM)
Last salesforce.com inc earnings: 2/25 04:06 pm
Check Earnings Report
US:NYSE Investor Relations:
investor.salesforce.com/about-us/investor/overview/default.aspx
Company Research
Source: Business Wire
SAN FRANCISCO--(BUSINESS WIRE)--Salesforce (NYSE: CRM), the world’s #1 CRM, today announced that AstraZeneca (LSE/STO/Nasdaq: AZN), a global, science-led biopharmaceutical company, has selected Agentforce Life Sciences for Customer Engagement to help transform its customer engagement globally, fostering stronger relationships with healthcare professionals (HCPs) through data-driven, AI-powered engagement. This work will support AstraZeneca's commitment to push the boundaries of science to deliver life-changing medicines in oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal and metabolism, and respiratory and immunology.With Agentforce Life Sciences, Salesforce aims to help AstraZeneca unlock a new era of intelligent engagement — redefining customer relationships and accelerating business growth. The partnership will enable teams to focus on strategic customer outcomes and meaningful customer interactions.Expanding its remit for AstraZeneca, Salesforce
Show less
Read more
Impact Snapshot
Event Time:
CRM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CRM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CRM alerts
High impacting Salesforce.com Inc news events
Weekly update
A roundup of the hottest topics
CRM
News
- Salesforce Announces Quarterly DividendBusiness Wire
- Salesforce Inc (CRM) Q3 2026 Earnings Call Highlights: Strong Revenue Growth and AI-Driven Expansion [Yahoo! Finance]Yahoo! Finance
- Salesforce (NYSE:CRM) had its price target raised by analysts at Northland Securities from $264.00 to $267.00. They now have a "market perform" rating on the stock.MarketBeat
- Salesforce (NYSE:CRM) had its price target raised by analysts at Macquarie from $250.00 to $265.00. They now have a "neutral" rating on the stock.MarketBeat
- Salesforce (NYSE:CRM) had its price target lowered by analysts at Truist Financial Corporation from $400.00 to $380.00. They now have a "buy" rating on the stock.MarketBeat
CRM
Earnings
- 12/3/25 - Beat
CRM
Sec Filings
- 12/4/25 - Form 10-Q
- 12/3/25 - Form 4
- 12/3/25 - Form 8-K
- CRM's page on the SEC website